Radiation therapy and breast cancer

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Radiation therapy is a cornerstone in breast cancer treatment.
• Uncertainties persist regarding optimal radiation strategies for specific patient groups and disease types.
• The evolving landscape of systemic therapy necessitates re-evaluation of local treatment modalities.

Purpose of the Study:

• To identify patient subgroups who benefit most from radiation therapy in breast conservation for ductal carcinoma in situ (DCIS).
• To determine the role of brachytherapy in managing invasive breast cancer, both as a standalone treatment and as a boost.
• To explore the potential for modifying radiation fields in breast conserving therapy, considering current systemic treatment efficacy.

Main Methods:

• Review of existing clinical trial data and meta-analyses.
• Analysis of recurrence rates in patients undergoing breast conserving therapy with systemic therapy.
• Evaluation of brachytherapy outcomes in invasive breast cancer cohorts.

Main Results:

• Identification of specific patient criteria for maximizing radiation benefit in DCIS and node-positive invasive breast cancer.
• Characterization of brachytherapy's efficacy as primary therapy and adjuvant boost in invasive disease.
• Evidence suggesting potential for reduced radiation field sizes in select patients receiving systemic therapy.

Conclusions:

• Refining patient selection for radiation therapy can optimize outcomes in DCIS and node-positive invasive breast cancer.
• Brachytherapy offers a valuable option in the management of invasive breast cancer.
• Systemic therapy advancements may allow for de-escalation of radiation volumes, reducing toxicity without compromising local control.